Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.59), which may not compare to the analyst estimate of ($0.08). Revenue for the quarter came in at $35.7 million versus the consensus estimate of $35.11 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.